Taiyixin’s affiliated enterprises added with permit of production of seven pesticide technical varieties

In January 2025, Heilongjiang Provincial Department of Agriculture and Rural Affairs approved expansion of pesticide production, as filed by Heilongjiang Lianshun Biotechnology Co., Ltd and Heilongjiang Xintai Biotechnology Co., Ltd. Both companies are primary members of Duowei Pharmaceutical Group, which is the same parent company of Ningxia Taiyixin Biotechnology Company, a well-known pesticide manufacturer in the agrochemical industry. The details of the expansion of permit of production are as follows:

Heilongjiang Lianshun Biotechnology Co., Ltd

Production location: Xinli Village, Zhongxinhe Town, Qiezihe District, Qitaihe City, Heilongjiang Province (Riverside Green Intelligent Industry Park)

Scope of production: Pesticide technical, including emamectin benzoate, abamectin, pymetrozine, tebuconazole and prochloraz.

Newly added technical varieties: Pymetrozine, tebuconazole and prochloraz.

Heilongjiang Xintai Biotechnology Co., Ltd

Production location: Xinli Village, Zhonghe Township, Eggplant River District, Qitaihe City, Heilongjiang Province (Riverside Green Intelligent Industry Park)

Scope of production: Pesticide technical, including indoxacarb, thiamethoxam, spirotetramat and boscalid.

Formulations: SL and AS.

Newly added technical varieties: Indoxacarb, thiamethoxam, spirotetramat and boscalid.

The expansion of permit of production signifies the further strategic product layout of Duowei Pharmaceutical Group in the pesticide sector. As a key member of the group in the field of pesticides, Ningxia Taiyixin is committed for years to production of avermectin and emamectin benzoate, enjoying a high reputation on the market due to its distinguished production process and superior product. The addition of the new productions of a number of blockbuster technical varieties in the Heilongjiang production base, combined with the glyphosate and glufosinate technical varieties launched by Ningxia Taiyixin in 2019, will further enrich the group’s product line and enhance its competitiveness on the pesticide market.

In addition, since its founding in 2019, Heilongjiang Lianshun Biotechnology Co., Ltd has demonstrated the steadfast determination of Duowei Pharmaceutical Group to grow pesticide business. The company’s registered capital has reached RMB4.066 billion yuan to support the planned total investment of RMB12 billion yuan, which covers 5,000 mu of land area, being committed to establishment of a green and intelligent pesticide production base.

Duowei Pharmaceutical Group says that going forward it will continue to add other pesticide technical varieties so as to provide global agricultural production with more agrochemical input solutions.